PROS1 and COVID-19: In addition, two Sanofi/GSK COVID-19 vaccines, code-named VAT0002 and VAT0008 (commercialized as Vidprevtyn) are adjuvanted recombinant S protein subunit vaccines and have been reported to show strong immune responses.